La farmac\u00e8utica FERRER, amb seu central a Barcelona, \u200b\u200bha anunciat el llan\u00e7ament de EPICUP, primer test diagn\u00f2stic epigen\u00e8tic que es basa en l’an\u00e0lisi de perfils de metilaci\u00f3 de l’ADN i ajuda al metge onc\u00f2leg a identificar el tumor primari en pacients amb c\u00e0ncer d’origen desconegut (CUP, segons la seva sigla en angl\u00e8s). <\/p>\n
L’eina, fruit de la col\u00b7laboraci\u00f3 publico-privada entre el Programa d’Epigen\u00e8tica i Biologia del C\u00e0ncer de l’Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), dirigit per Manel Esteller, la Unitat d\u2019Innovaci\u00f3 de l\u2019IDIBELL i l’\u00e0rea d’innovaci\u00f3 i desenvolupament de negoci de FERRER, presenta un alt grau d’exactitud. Aix\u00ed doncs, EPICUP esdev\u00e9 un bon complement a les metodologies diagn\u00f2stiques actualment utilitzades. <\/p>\n
Segons l’Organitzaci\u00f3 Mundial de la Salut, el c\u00e0ncer \u00e9s la principal causa de mort al m\u00f3n i es preveu un augment entre 2007 i 2030 el 45%, el que suposar\u00e0 m\u00e9s de 15 milions de nous casos i 11.3 milions de defuncions. \u201cSi b\u00e9 en l’\u00faltima d\u00e8cada\u201d explica Manel Esteller \u201cs’han aconseguit progressos molt importants pel que fa al diagn\u00f2stic de la malaltia, encara avui, el 5% dels pacients amb c\u00e0ncer s\u00f3n diagnosticats com a c\u00e0ncer d’origen desconegut\u201d. <\/p>\n
\u201cAquests pacients no nom\u00e9s presenten un pron\u00f2stic desfavorable\u201d, afegeix Carmen Bala\u00f1\u00e1 de l’Institut Catal\u00e0 d’Oncologia-Germans Trias i Pujol, \u201csin\u00f3 que a m\u00e9s davant el desconeixement del tumor que va donar origen a la met\u00e0stasi, se’ls administra un tractament de forma emp\u00edrica. Fet, que en molts casos, repercutir\u00e0 de forma negativa tant en l’evoluci\u00f3 de la malaltia com en la qualitat de vida del pacient\u201d. <\/p>\n
Conscients d’aquesta realitat, l’IDIBELL i FERRER han desenvolupat EPICUP amb la finalitat d’ajudar a diagnosticar el tumor primari i per tant a que el metge onc\u00f2leg pugui establir la pauta terap\u00e8utica m\u00e9s apropiada en cada cas. Aix\u00ed mateix, destaca Esteller, actualment estem treballant en la recerca de perfils de metilaci\u00f3 que ens ajudin a identificar quins tractaments podria ser sensible el tumor en q\u00fcesti\u00f3, l’objectiu ser\u00e0 complementar en el curt \/ mitj\u00e0 termini a EPICUP. <\/p>\n
This project has received funding from the European Research Council (ERC) under the European Union\u2019s Horizon 2020 research and innovation programme (grant agreement No 640696). <\/p>\n
FERRER \u00e9s una companyia qu\u00edmic-farmac\u00e8utica amb seu a Barcelona. Fundada el 1959, el grup abasta avui 45 empreses que desenvolupen les seves activitats a Europa, Am\u00e8rica Llatina, \u00c0frica, Orient Mitj\u00e0, \u00c0sia i els Estats Units. En total, els productes de salut de FERRER es comercialitzen en 93 pa\u00efsos a trav\u00e9s de 26 filials directes (incloent empreses conjuntes) i 70 socis i distribu\u00efdors. <\/p>\n
FERRER porta a terme activitats al llarg de tota la cadena de valor del medicament, des de la I + D fins a la comercialitzaci\u00f3 internacional, incl\u00f2s el desenvolupament de productes de qu\u00edmica fina, i la fabricaci\u00f3 de mat\u00e8ries primeres i productes farmac\u00e8utics.<\/p>\n","protected":false},"excerpt":{"rendered":"
Sobre Ferrer<\/p>\n","protected":false},"author":6,"featured_media":8121,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2024-11-12 13:19:48","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8120"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=8120"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8120\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/8121"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=8120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=8120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=8120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}